GlassScriptPhysician profile
Alexander Ochman
NPI 1316392970
$6,025.26
in general payments reported to CMS, 2019-2025
17 companies · $2,740 in 2025
The $2,740 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.18 · 2021: $513 · 2022: $1,343 · 2023: $726 · 2024: $632 · 2025: $2,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,503 · Travel and Lodging: $1,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,503.18 |
| Travel and Lodging | $1,595.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,287.15 | 2021-2025 | Solia, Selectra |
| Boston Scientific Corporation | $1,478.68 | 2022-2025 | Resonate El Icd Vr, General - Therapies, Watchman |
| Abbott Laboratories | $846.61 | 2021-2025 | Aveir, Gallant, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.01 | 2024-2025 | Lifevest |
| Amgen INC. | $201.06 | 2023-2025 | Repatha |
| Atricure, INC. | $175.45 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $153.57 | 2024 | Attain Command + Surevalve, Azure Xt Dr Mri Surescan, Selectsecure |
| Novartis Pharmaceuticals Corporation | $145.58 | 2024-2025 | |
| Artivion, INC. | $114.37 | 2023 | Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cardiac Non-Synergraft |
| Abiomed | $106.55 | 2023 | Impella |
| Impulse Dynamics (USA) INC. | $77.63 | 2023-2025 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $42.53 | 2024-2025 | Camzyos |
| Novo Nordisk INC | $38.26 | 2024 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $35.28 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $29.04 | 2024 | Wainua |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $19.16 | 2023 | Zio Xt Patch |
| United Therapeutics Corporation | $15.33 | 2024 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Ochman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.